STRASBOURG, France, Nov. 16, 2023 /PRNewswire/ -- Syndivia, a leading biotechnology company at the forefront of innovative DAR1 ADCs (antibody-drug conjugates with a drug-to-antibody ratio of 1), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback